| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate |
1995-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dff3abc602d50345425688309a736c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb45eabfd81752cbd981f993daeafb88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bc92f6839b471bf64db29ab3aac2663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32b722207badf0c1985f30f51d8f9f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640cc5a53508e53db4735e36d65f5143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_235c36f8be723ce2287464567c2424ae |
| publicationDate |
2002-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2189254-C2 |
| titleOfInvention |
Vaccines against hepatitis viruses |
| abstract |
FIELD: medicine, biotechnology, genetic therapy. SUBSTANCE: invention relates to vaccine against hepatitis viruses. Invention involves the nucleic acid molecule that comprises the not full genome of fused viruses of hepatitis C and hepatitis B or the not full genome of hepatitis C virus comprising the nucleotide sequence encoding the full core protein of hepatitis C and S-gene protein of hepatitis B, or the not full viral genome of hepatitis C comprising the nucleotide sequence encoding the full core protein of hepatitis C bound operatively with regulatory elements functioning in human cells. Invention describes also pharmaceutical compositions comprising such structures. The advantage of invention involves the development of gene structures that can be effective for protection against viruses of hepatitis B, and/or hepatitis C. EFFECT: enhanced effectiveness of vaccines. 1 4 cl, 3 dwg, 4 ex |
| priorityDate |
1995-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |